Cost implications of post-surgical morbidity following blood transfusion in cancer patients undergoing elective colorectal resection: an evaluation in the US hospital setting

Authors: Guest, Julian F.1; Ruiz, Francis J.1; Tang, Reiping2; Wang, Jeng-Yi2; Changchien, Chung R.2; Wexner, Steven3; Choti, Michael A.4

Source: Current Medical Research and Opinion, Volume 21, Number 3, March 2005 , pp. 447-456(10)

Publisher: Informa Healthcare

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Objective: To estimate the cost implications of blood transfusions and related surgical site infections (SSIs) in cancer patients undergoing elective colorectal resection in the hospital setting in the United States (US).

Study design: A modelling study was performed from the perspective of the hospital sector, based on published clinical outcomes from a study in Taiwan involving 2809 cancer patients who underwent elective colorectal resection using laparotomy and American treatment patterns.

Methods: Data on resource use were retrieved from published literature and from two American hospital centres specialising in colorectal cancer management. Decision analytical modelling was used to estimate the treatment costs and consequences of managing patients undergoing elective colorectal resection with and without blood transfusions.

Results: The expected treatment costs of managing patients who required and did not require a blood transfusion were estimated to be $19 869 (95% CI: 15 797; 23 150) and $14 586 (95% CI: 14 263; 14 886) per patient respectively. Expected treatment costs for those patients transfused with 1-3 units and > 3 units of blood were estimated to be $17 449 and $22 588 per patient respectively.

Conclusion: This is one of the first studies to specifically address the cost implications of postsurgical morbidity following colorectal resection in cancer patients. The cost of managing cancer patients undergoing elective colorectal resection who require a blood transfusion is expected to be 36% more than that of non-transfused patients, largely resulting from the development of SSIs.

Keywords: BLOOD TRANSFUSIONS; COLORECTAL CANCER; COSTS; ECONOMICS; RESOURCE USE; SURGICAL SITE INFECTIONS

Document Type: Research article

DOI: 10.1185/030079905X30734

Affiliations: 1: CATALYST Health Economics Consultants, Northwood, UK 2: Colorectal Section, Chang Gung Memorial Hospital, Taipei, Taiwan 3: Department of Colorectal Surgery, Cleveland Clinic, Weston, Florida, US 4: Department of Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, US

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$51.50 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A